MedTrace Logo

Biomedical HIV/AIDS Prevention Program Yunnan

NCT03992274 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2025-01-30

Study results available
· View outcomes & findings →

Summary

B-HAPPY is an implementation project to study the process by which pre-exposure prophylaxis (PrEP) is introduced and integrated into a specific international health system facing high rates of HIV incidence among men who have sex with men. The study will use a stepped wedge design to compare implementation outcomes across eight municipalities in Yunnan, China.

Conditions

Interventions

OTHER

Enhanced implementation of PrEP

During Enhanced Implementation study sites will receive Implementation Support to plan and introduce PrEP by following the eight stages of the PrEP-adapted SIC. Implementation Support specifically will involve a centralized technical assistance system developed using US-based PrEP experience focused on addressing implementation issues identified through real-time analysis of client, clinic, and implementation data.

Sponsors & Collaborators

  • Yunnan Center for Disease Control and Prevention

    collaborator OTHER

  • Oregon Social Learning Center

    collaborator OTHER

  • Hunter College of The City University of New York

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Kathrine Meyers, DrPH,MPP,MSc · Aaron Diamond AIDS Research Center, Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2023-09-27
Completion
2023-09-27

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03992274 on ClinicalTrials.gov